Protein mass fingerprinting by MALDI-TOF MS in combination with machine learning (PhenoMS-16 ML) permits the identification of response signatures generated in cell cultures upon exposure to well-17 characterized drugs. PhenoMS-ML is capable to identify and classify the mode of action of unknown 18 antibacterial agents in wild-type Escherichia coli and Staphylococcus aureus. It allows the sensitive, 19 specific, and high-throughput identification of drug target mechanisms that are difficult to assess by 20 other methods. 21
Bacterial culturing, compound treatment and MALDI-TOF MS were performed in 384-well format. 75
Mass spectral pre-processing was followed by data-dependent feature selection to identify peaks that 76 showed considerable changes in relative intensity upon treatment with antibiotics. Peaks selected for 77 the different models are listed in Supplementary Table 3 (E. coli data) and Supplementary Table 4 (S.  78 aureus data). An exemplary mass spectrum ( Figure 1A ) and details of two selected peaks for E.coli 79 are depicted in Figure 1B -C, and the corresponding data for S. aureus is provided in Supplementary 80 Figure 1A -C. Using the selected subsets of peaks, quadratic support vector machine classification 81 models (Q-SVM) were trained and internally validated using stratified 10-fold cross validation and 82 stratified 34% hold-out validation. A summary of the evaluated models and their corresponding 83 performance during internal and external validation is listed in Figure 1H . Binary classifiers were 84 trained to identify whether spectra belonged to cell cultures treated with or without an antibiotic. 85
Thus, the total data set for the binary classifiers contained spectra obtained for all seventeen 86 antibiotics at all assayed concentrations (1× to 0.031×MIC in 2-fold dilution series). As an example, 87 the confusion matrix of the 10-fold cross validated binary Q-SVM model of E. coli is given in Figure  88 1E, providing classification details of 908 mass spectra obtained for all antibiotics at all measured 89
concentrations. In addition, multiclass models were trained with the mode of action as class labels. 90
Antibiotics were grouped to the same classes based on the distinction of their target sites: cell wall 91 synthesis, CWL; protein synthesis, PRT; nucleic acid synthesis processing, DNA; or other mode of 92 action, OTH. The confusion matrix of the 10-fold cross validated mode of action model of E. coli is 93 given in Figure 1G . Details of internal validation of models on S. aureus data are provided in 94
Supplementary Table 5, Supplementary Table 6, Supplementary Table 7 and Supplementary Table 8 . 95 Moreover, mass spectra can paint an even more finely grained picture, as it allows for making the 96 distinction between antibiotics of the same class. We show that PhenoMS-ML is able to distinguish 97 between interference in cell wall synthesis caused by vancomycin and the interaction with penicillin-98 binding proteins by the β-lactams. Within the group of β-lactams, a further discrimination of target 99 profiles is possible, even at a fraction of the MIC (0.125×MIC, see Figure 1F ). Similarly, we were 100 able to distinguish (at 0.063×MIC) different target sites on bacterial ribosomes, which are difficult to 101 investigate by biochemical methods, see Supplementary Table 9 .
This set of blind drugs included antibiotic and non-antibiotic compounds, to assess both the binary 104 and mode of action classifiers. The binary model of E. coli was able to classify 95% of the mass 105 spectra to the correct class. Only the spectrum of cells treated with tiamulin was inadvertently 106 assigned as being untreated by the model. The mode of action model had an overall accuracy of 95% 107 as well. Interestingly, the mode of action model did correctly classify the spectrum from cells treated 108 with tiamulin as being treated with a protein synthesis inhibitor. The mode of action model only 109 inadvertently classified the spectrum from cells treated with nalidixic acid as being treated with a 110 protein synthesis inhibitor. Details of the external validation of models for E. coli data are provided in 111 Table 1Error ! Reference source not found.. Overall accuracy of binary and mode of action models 112 during external validation for S. aureus is comparable to E. coli. Details of the external validation of 113 the models for S. aureus are provided in Supplementary Table 10 . An aspect recognized here is that 114 the predictive power extends beyond the recognition of target sites in the training set. The external 115 validation set also included two probes (tiamulin and fusidic acid) that interfere with target sites 116 (peptidyl transferase unit of the 50S ribosomal subunit and the turnover of elongation factor-G from 117 the ribosome, respectively) not included in model training. 118
PhenoMS-ML offers a straightforward, high-throughput, label-free, and data-dependent access to 119 highly relevant antibiotic target sites. Additional advantages of the PhenoMS-ML procedure are, 120 contrary to typical MS-based assays, that it does not require tryptic digestion of protein samples, nor 121 does it require solvent and time-consuming liquid chromatography steps prior to sample ionization. 122
The resulting classification models reliably identify specific proteomic signatures induced by 123 interference with the most important target sites of antibiotics, such as cell wall metabolism, 124 ribosomal machinery, and nucleic acid processing, which are difficult to interrogate in biochemical 125 assays on isolated target proteins. Notably, biological responses can frequently be observed at low 126 levels of target interference, which allows the identification of weakly active hits with optimization 127
potential. This opens a perspective for fragment-based drug discovery in a phenotypic setting. As 128 indicated by ongoing studies, PhenoMS-ML can be extended towards eukaryotic systems. 
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Relative intensity of the peak at m/z 9293.5 decreases when treated with antibiotics (red) compared to untreated spectra 157 (black), regardless of antibiotic class or concentration. Note that for this subset of spectra at ⅛×MIC, the change of peak 158 intensity is even more pronounced for the peak at m/z 9275.2. However, the data-dependent feature selection did not elect 
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Nr. of features 7 8 
Drug name
⁄ Expected classification Binary MOA Brucine NA Inactive ✓ ✓ Ephedrine NA Inactive ✓ ✓ Ergotamine NA Inactive ✓ ✓ Fenbendazole NA Inactive ✓ ✓ Loperamide NA Inactive ✓ ✓ Metoprolol NA Inactive ✓ ✓ Paroxetine NA Inactive ✓ ✓ Sumatriptan NA Inactive ✓ ✓ Thalidomide NA Inactive ✓ ✓ Umifenovir NA Inactive ✓ ✓ Ampicillin 0.44
Material and methods

Medium and antibiotics
All experiments were performed using cation-adjusted Mueller-Hinton medium (MH medium; SigmaAldrich, Munich, Germany) prepared according to the manufacturers' guidelines. Antibiotics were selected to cover a diverse range of modes of action, listed in Supplementary Table 1 
MALDI-TOF settings
Target plates were positioned in the mass spectrometer (MALDI-TOF microflex LT, Bruker Daltonics, Bremen, Germany) fitted with a nitrogen laser (337 nm, set to 60 Hz). Spectra were acquired in linear mode with a mass range of m/z 2,000-15,000 using AutoXecute runs of the FlexControl software (Version 3.3, Build 108.2, Bruker Daltonics). The laser was set to fire 100 shots at 80% power per location (attenuator set to 20-30%), while moving in a small spiral raster over 7 locations per sample spot to assure appropriate signal intensity. The sum of 700 shots yielded spectra with ion intensities in the order of 10 4 -10 5 ion counts for the most abundant ions. Sample rate was set to 1.00 GS/s; detector gain was set to 3.7×; electronic gain was set to 200 mV and Realtime Smooth was disabled. Default delayed ion extraction was fixed at 140 ns. Calibration of the instrument was regularly evaluated using Brukers 'Protein Calibration Mix I' and, if necessary, adjusted accordingly.
Spectral pre-processing
Using Bruker's FlexAnalysis software, the collected raw spectra were exported to a *.txt file in ASCII format. Subsequently, the spectra were imported in MATLAB (R2018a; The MathWorks Inc., Natick, USA) installed on a desktop PC (i5-4690 CPU @3.50GHz equipped with 16 GB RAM and a 64-bit Windows 7 Professional operating system) and pre-processed as follows. First, spectra were resampled (MATLAB function msresample) in order to obtain a homogenous mass/charge (m/z) vector for each sample in the range of m/z 3850-15000. The baseline of each individual spectrum was estimated and subtracted using a sliding window filter (MATLAB function msbackadj). Noise was reduced using locally weighted scatter plot smoothing regression method (commonly referred to as LOWESS filter;
MATLAB function mslowess). Spectra were normalized to their total ion current (TIC; MATLAB function msnorm) and rescaled such that the highest peak in each mass spectrum had a relative intensity of 100%.
Spectral quality control
The TIC value was used as a measure for spectral quality. This eliminates the requirement to visually inspect each spectrum, which is a laborious and subjective task. Instead, the TIC allows for an objective verdict about the signal quality of the mass spectrum. Based on the TIC values of the whole dataset, the data was grouped into quartiles and the interquartile range (IQR) of the TIC was calculated. To determine outliers spectra from the bulk TIC data, the upper fence (UF) and the lower fence (LF) were computed using Equation 1 and Equation 2, as described previously by Tukey and coworkers (Tukey 1977 , Hoaglin, Iglewicz et al. 1986 ). = 1 + 1.5 ×
Equation 2
In Equation 1 and Equation 2, Q3 represents the third quartile (75th percentile) and Q1 the first quartile (25th percentile) of the TIC values. Spectra with TIC values above the upper fence or below the lower fence were considered outliers and removed from the dataset.
In addition, an outlier filter was added that removes any spectrum whose intensity was higher than the upper fence based on the intensity of the mass spectrum at m/z 12500 (where no peak was observed).
Therefore, the relative intensity at this m/z provides an easy way of removing spectra with poor signal quality. As a threshold, spectra with relative intensity above the third quartile plus two times the interquartile range at m/z 12500 (where no peak is expected) were removed. In practice, this threshold meant that all spectra with intensity roughly above 1-1.5% at m/z 12500 were removed.
Peak alignment and peak detection
Each mass spectrum was aligned towards known, conserved, and high intensity peaks (MATLAB function msalign). The majority of the proteins that can be observed in a typical E. coli mass spectrum are large and small ribosome-associated proteins (RL and RS) (Arnold and Reilly 1999) . By aligning spectra during the initial processing step towards several of these highly intense and consistently observed peaks, errors in peak location are reduced. In the case of mass spectra of E. coli, the peaks Computational time was approximately 2.35 seconds per spectrum, from importing the raw *.txt until peak detection using the mentioned computer and settings.
Feature selection
Not all peaks in the mass spectra contain sufficient discriminatory information for model construction.
Peaks may be removed from the dataset, as some peaks might cause overcomplicating and overfitting (poor generalization) of the models. Therefore, two types of feature selection algorithms have been applied in order to remove noisy and redundant peaks: (1) a random forest (RF) of decision trees and (2) sequential (forward; SFS and backward; SBS) feature selection. Features selected by two or all three of the applied feature selection methods (RF, SFS, and SBS) were considered for final model building.
Firstly, relative classification power of the peaks was evaluated using a random forest of decision trees, a so-called 'embedded' feature selection method (Breiman 2001) . A bootstrap aggregated ('bagged') random forest of 1000 decision trees was grown to evaluate the feature importance (MATLAB function TreeBagger). The amount of 1000 trees gives a good estimation of the feature importance considering the data size and complexity (Oshiro, Perez et al. 2012) . By evaluating the out-of-bag error, the relative importance of each peak regarding its impact on classification performance was evaluated. As a threshold, features with a relative feature importance higher than the mean importance plus one and a half standard deviation of the mean feature importance were considered for incorporation in the models. Subsequently, sequential feature selection (a 'wrapper' method) was used to select a subset of peaks that best classifies the data. Features considered for sequential feature selection were features that had a relative feature importance higher than the mean feature importance minus one standard deviation as determined by the RF. This was done in order to reduce calculation time, as sequential feature selection is a computationally expensive method.
During sequential feature selection, a subset of features was selected that best classified the data until there was no improvement in classification accuracy. This was done by creating an initial empty feature subset and subsequently adding more features (MATLAB function sequentialfs). Additionally, SBS was performed, where initially all features (that is: only the features with a relative feature importance higher than the mean feature importance minus one standard deviation as determined by the RF) were considered. In that case, features were removed from the initial subset, until accuracy no longer improved. For each new candidate feature subset (after adding or removal of a feature), a stratified 10-fold cross validation was performed. SFS selection was performed 100 times. Features were selected based on the mean amount of times they were selected (out of these 100 times) plus one and a half standard deviation of the amount of times they were selected. SBS selection was also performed 100 times using stratified 10-fold cross validation. As a threshold, features that were selected more than the mean amount of times they were selected (out of the 100 times) plus one standard deviation of the amount of times they were selected, were considered for modelling. If either the selection threshold for SFS or SBS was >100, which would result in no features selected, a threshold of >99 was taken.
Within the subgroup of cell wall synthesis inhibitors, at ⅛×MIC, features were selected in order to further discriminate between the β-lactams and vancomycin. Due to the relatively small amount of spectra in this particular subgroup, features were only evaluated using a random forest of decision trees.
The subgroup of protein synthesis inhibitors was also investigated at a fraction of the MIC (0.063×MIC) and only evaluated using a random forest of decision trees.
Model building and internal validation
Using the selected features and corresponding class labels (either the drug compound had 'activity' or 'no activity', or the mode of action, or the compound identity, as listed in Supplementary Table 1) , models were constructed under MATLAB's default settings in the classificationLearner application. It was found that quadratic Support Vector Machine-based (Q-SVM) classifying models performed among the best on our data sets. Therefore, in this work only Q-SVM models are discussed. The models were internally validated using a stratified 10-fold cross-validation and stratified 34% hold-out validation.
Model evaluation
Model performance was evaluated with the overall accuracy, a number between 0 and 1, indicating the fraction of spectra classified correctly (see Equation 3 ). In addition, for each class in the models, the recall and precision for each class are given, calculated according to Equation 4 and Equation 5 respectively. External validation
The trained models were externally validated by classifying the mode of action on novel data, which was explicitly not included in the model training phase. External validation was performed with a blind set of twenty compounds. These compounds were provided without any further information about their (mode of) activity, only that there were antibiotics and inactive compounds among them. These compounds were subjected to the PhenoMS-ML method, at a fixed concentration of 10 μM, a typical concentration in HTS campaigns. For the validation, two models were built for each bacterial strain.
One using a binary classifier, returning only whether the spectra belonged to cells treated with an antibiotic (outcome 'yes') or is untreated (outcome 'no activity'), and a second model that was built used the mode of action of the antibiotics as class labels (as listed in Supplementary Table 1 ).
In the case of S. aureus, treatment of cells with some of the compounds yielded spectra that were deemed of insufficient quality and therefore no classification could be performed. In these instances, it was assumed that the spectra were of insufficient quality due to the fact that the cells were treated with such copious amounts of antibiotic that insufficient cells had grown to generate a signal. These compounds were screened again, but at 1 μM screening concentration instead of 10 μM. For logistic reasons, the training set was reduced slightly: ciprofloxacin, vancomycin, trimethoprim, tetracycline, and nitrofurantoin were excluded for model training.
